Raoud Marayati

9PUBLICATIONS
15CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMolecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 14, 2025
A Novel Rexinoid Agonist, UAB116, Decreases Metastatic Phenotype in Hepatoblastoma by Inhibiting the Wnt/β-Catenin Pathway via Upregulation of <i>TRIM29</i>.

Swatika Butey, Morgan L Brown, Janet R Julson

|Jan 11, 2024
PIM Kinase Inhibition Attenuates the Malignant Progression of Metastatic Hepatoblastoma.

Janet R Julson, Colin H Quinn, Swatika Butey

|Jul 27, 2022
The Role of PIM Kinases in Pediatric Solid Tumors.

Janet Rae Julson, Raoud Marayati, Elizabeth Ann Beierle

|Apr 23, 2022
Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma.

Laura V Bownes, Raoud Marayati, Colin H Quinn

|Feb 15, 2022
Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy.

Colin H Quinn, Andee M Beierle, Sara Claire Hutchins

|Jul 02, 2021
Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines.

Laura V Bownes, Adele P Williams, Raoud Marayati

Pageof 2

Frequent Collaborators

8 joint publications

Elizabeth Ann Beierle

7 joint publications

Colin H Quinn

4 joint publications

Laura V Bownes

3 joint publications

Hooper R Markert